Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
49 results
  • Lung Cancer, Melanoma, Ovarian Cancer, Breast Cancer, Colorectal Cancer

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on

  • Ovarian Cancer, Sarcoma, Leukemia, Metastatic/Advanced Cancer, Breast Cancer, Lymphoma, Head and Neck Cancer

20-035          Phase II

A Multi-Center, Open Label Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in Patients With Relapsed/Refractory B-Cell Malignancies and Advanced Solid Tumors (View details on

  • Lung Cancer, Breast Cancer, Ovarian Cancer, Endometrial Cancer

16-393          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors (View details on

  • Breast Cancer, Prostate Cancer, Kidney Cancer, Head and Neck Cancer, Colorectal Cancer, Metastatic/Advanced Cancer, Liver Cancer

19-427          Phase I

A Phase 1 dose escalation study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors. (View details on

  • Ovarian Cancer, Colorectal Cancer, Lung Cancer, Breast Cancer

20-211          Phase I

A Phase 1 Study of SY-5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors (View details on

  • Lung Cancer, Ovarian Cancer, Endometrial Cancer, Colorectal Cancer, Breast Cancer

20-444          Phase I

A Phase 1, First-in-human Study of the Safety, Single- and Multiple-Dose Pharmacokinetics, and Preliminary Activity of Escalating Doses of RBN-2397, an Oral PARP7 Inhibitor, in Patients with Solid Tumors (View details on

  • Breast Cancer, Melanoma, Head and Neck Cancer

20-135          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of ONCR-177, an Oncolytic Herpes Simplex Virus for Intratumoral Injection, Alone and in Combination with PD-1 Blockade in Adult Subjects with Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors (View details on

  • Breast Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Lung Cancer

20-208          Phase I

A Phase 1/1B, Open-Label, Dose Escalation and Expansion Study of SBT6050 in Subjects With Advanced Solid Tumors Expressing HER2 (View details on

  • Breast Cancer

17-371          Phase II

A Phase 1/2 study for the safety, efficacy, pharmacokinetic and pharmacodynamics evaluation of SAR439859, administered orally as monotherapy, then in combination with other anti-cancer therapies in postmenopausal women with estrogen receptor-positive advanced breast cancer (View details on

  • Breast Cancer

20-449          Phase II

A Phase 1/2, open-label, dose escalation, and cohort expansion clinical trial to evaluate the safety, tolerability, and pharmacokinetics of ARV-471 in patients with ER+/HER2- locally advanced or metastatic breast cancer, who have received prior hormonal therapy and chemotherapy in the locally advanced/metastatic setting (View details on

Showing 1 - 10 of 49 results